Low-Density Lipoprotein Cholesterol Levels and Bleeding Risk in Venous Thromboembolism.
作者信息
Siniscalchi Carmine, Meschi Tiziana, Di Micco Pierpaolo, Imbalzano Egidio, Hernández-Blasco Luis, Mahé Isabelle, Fernández-Reyes José Luis, García-Ortega Alberto, Verhamme Peter, Alfonso-Megido Joaquín, Monreal Manuel
机构信息
Department of Internal Medicine, Parma University Hospital, Parma, Italy.
AFO Medicina PO Santa Maria delle Grazie, Pozzuoli Naples Hospital 2 Nord, Naples, Italy.
出版信息
JAMA Netw Open. 2025 May 1;8(5):e259467. doi: 10.1001/jamanetworkopen.2025.9467.
Abstract
摘要
相似文献
1
Low-Density Lipoprotein Cholesterol Levels and Bleeding Risk in Venous Thromboembolism.静脉血栓栓塞症中的低密度脂蛋白胆固醇水平与出血风险
JAMA Netw Open. 2025 May 1;8(5):e259467. doi: 10.1001/jamanetworkopen.2025.9467.
2
Extended-phase anticoagulant treatment of acute venous thromboembolism in children: a cohort study from the EINSTEIN-Jr phase 3 trial.儿童急性静脉血栓栓塞症的延长阶段抗凝治疗：来自EINSTEIN-Jr 3期试验的队列研究
Lancet Haematol. 2025 May;12(5):e357-e364. doi: 10.1016/S2352-3026(25)00067-5. Epub 2025 Apr 10.
3
Anticoagulation duration in heterozygous factor V Leiden: a decision analysis.杂合子因子 V Leiden 抗凝持续时间：决策分析。
Thromb Res. 2013;132(6):724-8. doi: 10.1016/j.thromres.2013.09.012. Epub 2013 Sep 16.
4
Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation.静脉血栓栓塞症和因子 V 莱顿或凝血酶原 20210 突变携带者在抗凝过程中的患者结局。
Am J Med. 2017 Apr;130(4):482.e1-482.e9. doi: 10.1016/j.amjmed.2016.11.016. Epub 2016 Dec 14.
5
Safety and feasibility of therapeutic anticoagulation for newly diagnosed venous thromboembolism in women who undergo neoadjuvant chemotherapy for advanced ovarian cancer.新辅助化疗治疗晚期卵巢癌患者中诊断性静脉血栓栓塞症的治疗抗凝的安全性和可行性。
Int J Gynecol Cancer. 2024 Jan 5;34(1):113-121. doi: 10.1136/ijgc-2023-004576.
6
Incidence of venous thromboembolism and hemorrhage related safety studies of preoperative anticoagulation therapy in hip fracture patients undergoing surgical treatment: a case-control study.髋部骨折手术治疗患者术前抗凝治疗相关静脉血栓栓塞和出血的发生率及安全性研究：一项病例对照研究
BMC Musculoskelet Disord. 2016 Feb 12;17:76. doi: 10.1186/s12891-016-0917-y.
7
IMPROVE bleeding score predicts major bleeding in advanced gastrointestinal cancer patients with venous thromboembolism.IMPROVE出血评分可预测晚期胃肠道癌合并静脉血栓栓塞患者的大出血情况。
Jpn J Clin Oncol. 2022 Oct 6;52(10):1183-1190. doi: 10.1093/jjco/hyac103.
8
The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism.美国胸科医师学院评分评估静脉血栓栓塞症患者抗凝治疗期间出血风险。
J Thromb Haemost. 2018 Oct;16(10):1994-2002. doi: 10.1111/jth.14253. Epub 2018 Aug 24.
9
Anticoagulation period in idiopathic venous thromboembolism. How long is enough?特发性静脉血栓栓塞症的抗凝期。多长时间足够？
Saudi Med J. 2004 Jul;25(7):848-51.
10
Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study.依度沙班用于静脉血栓栓塞症患者的延长抗凝治疗：来自北斋-VTE研究的事后分析
Lancet Haematol. 2016 May;3(5):e228-36. doi: 10.1016/S2352-3026(16)00023-5. Epub 2016 Mar 22.
引用本文的文献
1
Low LDL-Cholesterol and Hemorrhagic Risk: Mechanistic Insights and Clinical Perspectives.低低密度脂蛋白胆固醇与出血风险：机制洞察与临床视角
Int J Mol Sci. 2025 Jun 11;26(12):5612. doi: 10.3390/ijms26125612.
本文引用的文献
1
Low LDL-C level and intracranial haemorrhage risk after ischaemic stroke: a prospective cohort study.低 LDL-C 水平与缺血性脑卒中后颅内出血风险：一项前瞻性队列研究。
Stroke Vasc Neurol. 2023 Apr;8(2):127-133. doi: 10.1136/svn-2022-001612. Epub 2022 Sep 26.
2
LDL cholesterol levels and in-hospital bleeding in patients on high-intensity antithrombotic therapy: findings from the CCC-ACS project.高强度抗血栓治疗患者的 LDL 胆固醇水平与院内出血：来自 CCC-ACS 项目的研究结果。
Eur Heart J. 2021 Aug 31;42(33):3175-3186. doi: 10.1093/eurheartj/ehab418.
3
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.2019年欧洲心脏病学会/欧洲动脉粥样硬化学会血脂异常管理指南：通过血脂修饰降低心血管风险
Eur Heart J. 2020 Jan 1;41(1):111-188. doi: 10.1093/eurheartj/ehz455.
4
Causal associations of blood lipids with risk of ischemic stroke and intracerebral hemorrhage in Chinese adults.血脂与中国成年人缺血性卒中和脑出血风险的因果关联。
Nat Med. 2019 Apr;25(4):569-574. doi: 10.1038/s41591-019-0366-x. Epub 2019 Mar 11.
5
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2018 年美国心脏病学会/美国心脏协会/美国心血管血管造影和介入学会/美国预防、物理治疗和康复医师学会/美国糖尿病协会/美国老年学会/美国药学会/美国医师协会/美国生理学会/北美介入放射学会/美国国家脂质协会/美国临床内分泌医师协会胆固醇管理指南：美国心脏病学会/美国心脏协会临床实践指南工作组的报告。
Circulation. 2019 Jun 18;139(25):e1082-e1143. doi: 10.1161/CIR.0000000000000625. Epub 2018 Nov 10.
6
Rationale, Design and Methodology of the Computerized Registry of Patients with Venous Thromboembolism (RIETE).静脉血栓栓塞症患者计算机化登记处（RIETE）的原理、设计和方法学。
Thromb Haemost. 2018 Jan;118(1):214-224. doi: 10.1160/TH17-07-0511. Epub 2018 Jan 5.
Zotero 插件